Navigation Links
NOVAVAX Announces Closing of Public Offering of 6,800,000 Shares of Common Stock
Date:12/9/2009

ax

Novavax, Inc. is a clinical-stage biotechnology company, creating novel vaccines to address a broad range of infectious diseases worldwide, including H1N1, using advanced proprietary virus-like-particle (VLP) technology.

Forward-Looking Statements

This press release contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act. Novavax cautions that these forward-looking statements are subject to numerous assumptions, risks and uncertainties, which change over time. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company, or industry results, to be materially different from those expressed or implied by such forward-looking statements. Such factors include, among other things, the following: our ability to satisfy all required closing conditions if the option is exercised; our ability to obtain adequate financing in the future through product licensing, co-promotional arrangements, public or private equity or debt financing or otherwise; general business conditions; competition; business abilities and judgment of personnel; and other factors referenced herein. Further information on the factors and risks that could affect Novavax's business, financial conditions and results of operations, is contained in Novavax's filings with the Securities and Exchange Commission, which are available at http://www.sec.gov. These forward-looking statements speak only as of the date of this press release, and Novavax assumes no duty to update forward-looking statements.

SOURCE Novavax, Inc.


'/>"/>
SOURCE Novavax, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Novavax CEO to Present at ACUMENBioFins 9th Annual Healthcare Conference
2. Novavax Reports Third Quarter 2007 Financial Results and Progress with Vaccine Development Programs
3. GE Healthcare and Novavax Establish Collaboration To Develop and Market Pandemic Influenza Solution
4. Novavax Announces Preclinical Results for Seasonal Influenza Vaccine Program
5. Novavax Announces Favorable Interim Results from Human Clinical Trial for Its Pandemic Influenza Vaccine Program
6. Novavax Reports Fourth Quarter and 2007 Year-End Financial Results
7. Novavax Reports Positive Results from Preclinical Studies of its VLP-based Trivalent Seasonal Influenza Vaccine Candidate
8. Novavax Completes Enrollment in Phase I/IIa Pandemic Influenza Vaccine Clinical Trial
9. Novavax Announces Proprietary Method to Create SARS Vaccine and Renewal of NIH Funding for SARS Vaccine Development
10. Novavax to Present Phase I/IIa Trial Data Results in an Investor Conference Call on August 26, 2008
11. Novavax Announces Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... 2015 Varian Medical Systems, Inc., (NYSE: VAR ... European subsidiaries, agreed to acquire Claymount, a privately-held, ... for X-ray imaging equipment manufacturers. Varian,s subsidiary in ... in cash for Claymount. The transaction is expected to ... one of the world,s leading suppliers of high voltage ...
(Date:7/29/2015)... July 29, 2015  Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: ... for the second quarter ended June 30, 2015. ... both HETLIOZ and Fanapt" said Mihael H. Polymeropoulos M.D., ... and life cycle management of our products set the ...   Financial Highlights , Total net ...
(Date:7/29/2015)... Asterias Biotherapeutics, Inc. (NYSE MKT: AST), a ... medicine, today announced that it will release second quarter ... after the close of the U.S. financial markets. The ... Monday, August 10, 2015 at 4:30 p.m. Eastern / ... developments. For both "listen-only" participants and those ...
Breaking Medicine Technology:Varian Medical Systems Acquiring Claymount to Expand Imaging Components Portfolio 2Varian Medical Systems Acquiring Claymount to Expand Imaging Components Portfolio 3Varian Medical Systems Acquiring Claymount to Expand Imaging Components Portfolio 4Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 2Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 3Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 4Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 5Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 6Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 7Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 8Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 9Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 10Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 11Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 12Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 13Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 14Asterias Biotherapeutics to Report Second Quarter Results on August 10, 2015 2
... Cleveland Clinic Researchers Highlight the Need For More Women to ... ... Cleveland Clinic,researchers have recently found that women remain a significant ... and Blood Institute (NHLBI). Lead Author, Esther S.H. Kim, ...
... cold dissection ... procedure, ... company, today announced that a study published in,the Annals of Otology, ... Technology in total tonsillectomy,patients resulted in significantly less intraoperative blood loss ...
Cached Medicine Technology:Enrollment of Women in Cardiovascular Trials Fails to Meet Current Federal Mandates 2Study Finds Starion Instruments' Tissue Welding Technology Reduces Pain and Bleeding in Tonsillectomy Patients 2
(Date:7/29/2015)... TX (PRWEB) , ... July 29, 2015 , ... ... comprehensive information on the therapeutic development for Atherosclerosis. Atherosclerosis is a slow, progressive ... new targets and MOAs to produce first-in-class and best-in-class products. Complete report on ...
(Date:7/29/2015)... ... 2015 , ... Topical BioMedics, Inc., announces it has partnered ... Cream designated as the nonprofit’s natural pain reliever of choice.     , 555 ... Deaths (LODD) and the high rate of pain and injuries firefighters are suffering ...
(Date:7/29/2015)... FL (PRWEB) , ... July 29, 2015 , ... ... e-cigarette shops are anticipating testing regulations imposed by the FDA for nicotine laced ... but use of electronic cigarettes have raised considerably. E-Cigarettes are particularly troublesome to ...
(Date:7/29/2015)... ... July 29, 2015 , ... San Fernando Valley skin doctor , Dr. ... time only, patients can get the complete treatment process with a 10 percent discount ... non-invasive treatment and have loose or sagging skin. , As the only non-surgical ...
(Date:7/29/2015)... ... 2015 , ... Wedding season is in full swing, which means bridal beauty prep is officially ... on the big day. Every bride wants to look and feel beautiful, but a recent ... to a recent study by the American Academy of Facial Plastic and ...
Breaking Medicine News(10 mins):Health News:Atherosclerosis Pipeline Assessment Review H1 2015 Market Research Report Available at RnRMarketResearch.com 2Health News:Atherosclerosis Pipeline Assessment Review H1 2015 Market Research Report Available at RnRMarketResearch.com 3Health News:Atherosclerosis Pipeline Assessment Review H1 2015 Market Research Report Available at RnRMarketResearch.com 4Health News:Topical BioMedics Partners with 555 Fitness: Topricin® Designated as the Nonprofit’s Natural Pain Reliever of Choice 2Health News:Topical BioMedics Partners with 555 Fitness: Topricin® Designated as the Nonprofit’s Natural Pain Reliever of Choice 3Health News:Topical BioMedics Partners with 555 Fitness: Topricin® Designated as the Nonprofit’s Natural Pain Reliever of Choice 4Health News:Topical BioMedics Partners with 555 Fitness: Topricin® Designated as the Nonprofit’s Natural Pain Reliever of Choice 5Health News:Topical BioMedics Partners with 555 Fitness: Topricin® Designated as the Nonprofit’s Natural Pain Reliever of Choice 6Health News:Harbor Village Urges South Florida Residents to Abstain from the Use of E Cigarettes 2Health News:Harbor Village Urges South Florida Residents to Abstain from the Use of E Cigarettes 3Health News:San Fernando Valley Dermatology Office, Castle Dermatology Institute, is Now Offering a Promotional Price on Ultherapy 2Health News:Say I Do To Surgery: Bridal Beauty On The Rise According to New Survey 2Health News:Say I Do To Surgery: Bridal Beauty On The Rise According to New Survey 3
... spoke on the House floor this afternoon in support ... which provides,$50 billion over five years for programs to ... remarks:, "I want to commend Chairman Howard Berman ... to come out of the Foreign Affairs Committee under,your ...
... for proposing less governance of the practice , , ... Drug Administration draft guidelines for oversight of off-label drug ... for unapproved uses, one expert contends. , The proposed ... Randall Stafford, an associate professor of medicine at the ...
... to dramatically reduce their dose of these often harsh ... Medicine in St. Louis have taken a step closer ... drug directly on tumors in rabbits using drug-coated nanoparticles. ... than used previously for this purpose markedly slowed tumor ...
... IPC,The Hospitalist Company, Inc. (Nasdaq: IPCM ), a ... has been established,as the date of its 2008 Annual ... business on April 22, 2008 will be entitled to,receive ... which will be held,at the Hilton Los Angeles, 555 ...
... Blacksburg, Va. A research team from the Virginia ... superfamily of pathogen genes involved in the infection of ... plant pathogens Phytophthora ramorum and Phytophthora sojae. The pathogen ... work in such a way as to make the ...
... 2, 2008 Henry Nicholas,president of the 150,000-member ... AFL-CIO, announced today that his 16000-plus members of,the ... of the,United Child Care Union across Pennsylvania will ... primary., "We need change," Nicholas told delegates ...
Cached Medicine News:Health News:Pelosi on Global HIV/AIDS Bill: 'There is a Moral Imperative to Combat This Epidemic' 2Health News:Pelosi on Global HIV/AIDS Bill: 'There is a Moral Imperative to Combat This Epidemic' 3Health News:Off-Label Drug Use Needs Strong Oversight 2Health News:Nano-sized technology has super-sized effect on tumors 2Health News:Nano-sized technology has super-sized effect on tumors 3Health News:IPC The Hospitalist Company Sets 2008 Annual Meeting Date 2Health News:Huge virulence gene superfamily responsible for devastating plant diseases 2
... The Accutest Infectious Mononucleosis Whole ... test used for the detection of ... (IM) in human whole blood. This ... help in the diagnosis of IM ...
... test for the visual, qualitative ... to infectious mononucleosis in human ... specimens. This test is intended ... diagnosis of infectious mononucleosis in ...
... Influenza A+B test allows for the ... A and type B antigens directly ... nasal aspirate specimens. The test is ... rapid differential diagnosis of acute influenza ...
The NOW® Flu B test is the most frequently adopted rapid flu test on the market today. Testing could not be easier and the results are available in 15 minutes. Now you can focus on the results an...
Medicine Products: